News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Eisai Inc. Divests Clinical Diagnostics Supply Biz for $183 Million
November 30, 2015
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Eisai will sell its clinical diagnostics business – EIDIA Co. Ltd - to Sekisui Chemical for JPY 22.4bn ($183m).
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Asia
Eisai Inc.
MORE ON THIS TOPIC
Deals
Angelini inks $4.1B Catalyst buy to enter US rare disease market
May 7, 2026
·
2 min read
·
Gabrielle Masson
Weight loss
GSK goes beyond weight-loss with $1B buyout of Chinese siRNA specialist
May 7, 2026
·
2 min read
·
Tristan Manalac
Job Trends
Increased capital boosts biotech R&D job postings, employment
May 7, 2026
·
4 min read
·
Angela Gabriel
Manufacturing
Amgen, Sanofi commit nearly $600M to North American expansions
May 6, 2026
·
2 min read
·
Nick Paul Taylor
